Mitchell Kapoor
Stock Analyst at HC Wainwright & Co.
(1.24)
# 3,522
Out of 4,884 analysts
345
Total ratings
33.77%
Success rate
-16.06%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Mitchell Kapoor
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| TYRA Tyra Biosciences | Reiterates: Buy | $30 | $10.00 | +200.00% | 20 | Jul 1, 2025 | |
| SMMT Summit Therapeutics | Reiterates: Buy | $44 | $24.55 | +79.23% | 14 | Jul 1, 2025 | |
| CRSP CRISPR Therapeutics AG | Reiterates: Buy | $65 | $52.17 | +24.59% | 4 | Jun 27, 2025 | |
| IONS Ionis Pharmaceuticals | Reiterates: Buy | $50 | $43.00 | +16.28% | 4 | Jun 26, 2025 | |
| SRPT Sarepta Therapeutics | Downgrades: Sell | $40 → $10 | $18.24 | -45.18% | 14 | Jun 25, 2025 | |
| LYEL Lyell Immunopharma | Maintains: Neutral | $1 → $10 | $9.69 | +3.20% | 13 | Jun 24, 2025 | |
| VERV Verve Therapeutics | Downgrades: Neutral | $14 | $11.28 | +19.68% | 7 | Jun 18, 2025 | |
| NTLA Intellia Therapeutics | Reiterates: Buy | $30 | $10.74 | +179.33% | 4 | Jun 16, 2025 | |
| TIL Instil Bio | Reiterates: Buy | $125 | $27.50 | +354.55% | 17 | Jun 5, 2025 | |
| AVTX Avalo Therapeutics | Assumes: Buy | $15 | $4.96 | +202.42% | 1 | Jun 2, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $5 | $1.07 | +367.29% | 1 | Jun 2, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $72 | $54.00 | +33.33% | 36 | May 29, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | $4 → $5 | $2.81 | +77.94% | 7 | May 27, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $5 | $2.50 | +100.00% | 10 | May 20, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $23 → $15 | $4.45 | +237.08% | 8 | May 16, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $50 → $45 | $20.09 | +123.99% | 15 | May 13, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $115 → $100 | $13.35 | +649.06% | 12 | May 8, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $14 | $3.40 | +311.76% | 12 | Apr 30, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $3 | $2.57 | +16.73% | 1 | Apr 28, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $75 | $35.64 | +110.44% | 37 | Apr 16, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $40 | $11.21 | +256.82% | 17 | Apr 9, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $0.33 | - | 20 | Apr 9, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $14 → $7 | $1.67 | +319.16% | 9 | Apr 3, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $5 → $3 | $1.13 | +165.49% | 6 | Apr 3, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $5 → $2 | $0.56 | +260.30% | 16 | Apr 3, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $9 | $0.54 | +1,580.99% | 15 | Apr 3, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $15 | $5.89 | +154.67% | 2 | Mar 24, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $45 | $12.60 | +257.14% | 5 | Feb 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $0.40 | - | 12 | Dec 16, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $40,000 → $610,000 | $1.23 | +49,593,395.93% | 2 | Sep 6, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Neutral | n/a | $3.34 | - | 4 | Jun 2, 2023 |
Tyra Biosciences
Jul 1, 2025
Reiterates: Buy
Price Target: $30
Current: $10.00
Upside: +200.00%
Summit Therapeutics
Jul 1, 2025
Reiterates: Buy
Price Target: $44
Current: $24.55
Upside: +79.23%
CRISPR Therapeutics AG
Jun 27, 2025
Reiterates: Buy
Price Target: $65
Current: $52.17
Upside: +24.59%
Ionis Pharmaceuticals
Jun 26, 2025
Reiterates: Buy
Price Target: $50
Current: $43.00
Upside: +16.28%
Sarepta Therapeutics
Jun 25, 2025
Downgrades: Sell
Price Target: $40 → $10
Current: $18.24
Upside: -45.18%
Lyell Immunopharma
Jun 24, 2025
Maintains: Neutral
Price Target: $1 → $10
Current: $9.69
Upside: +3.20%
Verve Therapeutics
Jun 18, 2025
Downgrades: Neutral
Price Target: $14
Current: $11.28
Upside: +19.68%
Intellia Therapeutics
Jun 16, 2025
Reiterates: Buy
Price Target: $30
Current: $10.74
Upside: +179.33%
Instil Bio
Jun 5, 2025
Reiterates: Buy
Price Target: $125
Current: $27.50
Upside: +354.55%
Avalo Therapeutics
Jun 2, 2025
Assumes: Buy
Price Target: $15
Current: $4.96
Upside: +202.42%
Jun 2, 2025
Initiates: Buy
Price Target: $5
Current: $1.07
Upside: +367.29%
May 29, 2025
Reiterates: Buy
Price Target: $72
Current: $54.00
Upside: +33.33%
May 27, 2025
Upgrades: Buy
Price Target: $4 → $5
Current: $2.81
Upside: +77.94%
May 20, 2025
Reiterates: Buy
Price Target: $5
Current: $2.50
Upside: +100.00%
May 16, 2025
Maintains: Buy
Price Target: $23 → $15
Current: $4.45
Upside: +237.08%
May 13, 2025
Maintains: Buy
Price Target: $50 → $45
Current: $20.09
Upside: +123.99%
May 8, 2025
Maintains: Buy
Price Target: $115 → $100
Current: $13.35
Upside: +649.06%
Apr 30, 2025
Reiterates: Buy
Price Target: $14
Current: $3.40
Upside: +311.76%
Apr 28, 2025
Initiates: Buy
Price Target: $3
Current: $2.57
Upside: +16.73%
Apr 16, 2025
Reiterates: Buy
Price Target: $75
Current: $35.64
Upside: +110.44%
Apr 9, 2025
Reiterates: Buy
Price Target: $40
Current: $11.21
Upside: +256.82%
Apr 9, 2025
Downgrades: Neutral
Price Target: n/a
Current: $0.33
Upside: -
Apr 3, 2025
Maintains: Buy
Price Target: $14 → $7
Current: $1.67
Upside: +319.16%
Apr 3, 2025
Maintains: Neutral
Price Target: $5 → $3
Current: $1.13
Upside: +165.49%
Apr 3, 2025
Maintains: Buy
Price Target: $5 → $2
Current: $0.56
Upside: +260.30%
Apr 3, 2025
Reiterates: Buy
Price Target: $9
Current: $0.54
Upside: +1,580.99%
Mar 24, 2025
Reiterates: Buy
Price Target: $15
Current: $5.89
Upside: +154.67%
Feb 7, 2025
Reiterates: Buy
Price Target: $45
Current: $12.60
Upside: +257.14%
Dec 16, 2024
Downgrades: Neutral
Price Target: n/a
Current: $0.40
Upside: -
Sep 6, 2023
Maintains: Buy
Price Target: $40,000 → $610,000
Current: $1.23
Upside: +49,593,395.93%
Jun 2, 2023
Reiterates: Neutral
Price Target: n/a
Current: $3.34
Upside: -